Ameriprise Financial Inc Rocket Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $22,725 - $47,507	2,855 Added 3.57%	82,720 $1.14 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $526 - $947	-40 Reduced 0.05%	79,865 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $183,996 - $307,971	8,550 Added 11.98%	79,905 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $76,090 - $135,891	-2,775 Reduced 3.74%	71,355 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $968,224 - $1.16 Million	24,568 Added 49.57%	74,130 $3.28 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $159,447 - $242,482	-3,679 Reduced 6.91%	49,562 $2.2 Million
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $1.24 Million - $3.17 Million	53,241 New	53,241 $2.92 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.